Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study - Ochoa-Gondar, Olga; Vila-Corcoles, Angel; Rodriguez-Blanco, Teresa; Gomez-Bertomeu, Frederic; Figuerola-Massana, Enric; Raga-Luria, Xavier; Hospital-Guardiola, Imma (Clinical infectious diseases, 2014)
Keywords: Aged; Aged, 80 and over; ARTICLES AND COMMENTARIES; Bacterial diseases; Biological and medical sciences; Community-Acquired Infections - epidemiology; Community-Acquired Infections - mortality; Community-Acquired Infections - prevention & control; Female; Follow-Up Studies; Heart diseases; Hospitalization; Human bacterial diseases; Humans; Immunization; Incidence; Infectious diseases; Influenza vaccines; Lung diseases; Male; Medical sciences; Middle Aged; Nursing homes; Older adults; Older people; Place of residence; Pneumococcal pneumonia; Pneumococcal vaccines; Pneumococcal Vaccines - therapeutic use; Pneumology; Pneumonia; Pneumonia, Pneumococcal - epidemiology; Pneumonia, Pneumococcal - mortality; Pneumonia, Pneumococcal - prevention & control; Prospective Studies; Respiratory system : syndromes and miscellaneous diseases; Spain - epidemiology; Staphylococcal infections, streptococcal infections, pneumococcal infections; Strokes; Vaccines; Spain; Lung disease; Pneumonia; Respiratory disease; Vaccine; Streptococcus pneumoniae; Infection; Prevention; Streptococcaceae; Immunoprophylaxis; Community acquired infection; Follow up study; Streptococcal infection; Bacteriosis; Bacteria; Micrococcales; Pneumococcal infection; Polysaccharide; pneumonia; pneumococcal vaccination; elderly